Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D002036:Bundle of His / Q000187:drug effects / Q000503:physiopathology; D002304:Cardiac Pacing, Artificial; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology; D004594:Electrophysiology; D005260:Female; D005424:Flecainide; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage* / Q000097:blood; D012849:Sinoatrial Node / Q000187:drug effects / Q000503:physiopathology; D013610:Tachycardia / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D005424:Flecainide